|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
27
|
|
pubmed:dateCreated |
2007-9-19
|
|
pubmed:abstractText |
The randomized controlled European Organisation for Research and Treatment of Cancer (EORTC) trial 22911 studied the effect of radiotherapy after prostatectomy in patients with adverse risk factors. Review pathology data of specimens from participants in this trial were analyzed to identify which factors predict increased benefit from adjuvant radiotherapy.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-21,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-22,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-23,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-24,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-25,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-26,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-27,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-28,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-29,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-30,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-31,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-32,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-33,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-34,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-35,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-36,
http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-37
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BollaMichelM,
pubmed-author:BossetJean-FrancoisJF,
pubmed-author:ColletteLaurenceL,
pubmed-author:Da PozzoLuigiL,
pubmed-author:EORTC 22911,
pubmed-author:KurthKarl HKH,
pubmed-author:SchröderFritz HFH,
pubmed-author:Van CanghPaulP,
pubmed-author:Van PoppelHeinH,
pubmed-author:Van der KwastTheodorus HTH,
pubmed-author:VekemansKrisK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4178-86
|
|
pubmed:dateRevised |
2008-5-14
|
|
pubmed:meshHeading |
pubmed-meshheading:17878474-Aged,
pubmed-meshheading:17878474-Combined Modality Therapy,
pubmed-meshheading:17878474-Disease Progression,
pubmed-meshheading:17878474-Disease-Free Survival,
pubmed-meshheading:17878474-Europe,
pubmed-meshheading:17878474-Humans,
pubmed-meshheading:17878474-Male,
pubmed-meshheading:17878474-Middle Aged,
pubmed-meshheading:17878474-Proportional Hazards Models,
pubmed-meshheading:17878474-Prostate-Specific Antigen,
pubmed-meshheading:17878474-Prostatectomy,
pubmed-meshheading:17878474-Prostatic Neoplasms,
pubmed-meshheading:17878474-Risk Factors,
pubmed-meshheading:17878474-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
|
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University Health Network, Toronto, Canada. theo.vdkwast@uhn.on.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
